SCHEDULE: InspireMD CFO Boosts Stake, Gains Proxy Control

InspireMD's CFO, Michael A. Lawless, reports beneficial ownership of 8.6% of common stock, including new equity grants and voting control over employee shares.

Summary

• Michael A. Lawless, Chief Financial Officer of InspireMD, Inc., filed a Schedule 13D reporting beneficial ownership of 3,614,731 shares of the company's common stock, representing 8.6% of the class.
• This beneficial ownership primarily stems from irrevocable proxy agreements with employees who received restricted stock under the company's 2013 and 2021 Long-Term Incentive Plans.
• As of the reporting date, 3,412,465 shares are subject to these Proxy Agreements, representing approximately 8.2% of the combined voting power of the company's outstanding common stock.
• The Proxy Agreements grant Mr. Lawless (or a board-designated person) sole and absolute discretion to vote these employee shares.
• On June 25, 2025, Mr. Lawless also received a personal grant of 465,000 restricted shares and options to purchase 212,000 shares under the 2024 Inducement Plan.
• These personal grants vest in three equal annual installments, with 1/3 vesting on June 25, 2026, June 25, 2027, and June 25, 2028, subject to his continued service.
• The shares beneficially owned by Mr. Lawless (3,614,731 shares) do not include these newly granted restricted shares or options.
• The total shares issued and outstanding as of August 4, 2025, were 41,720,662.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of beneficial ownership by a key executive, including new equity grants and a governance mechanism for employee shares. It indicates alignment of interests but does not present new financial performance data or significant strategic shifts, thus having a neutral to slightly positive sentiment.

Positives

• The CFO's increased beneficial ownership, primarily through voting control over employee shares, enhances alignment between management and shareholder interests.
• The equity grants to the CFO (465,000 restricted shares and 212,000 options) further align his long-term incentives with the company's performance.
• The establishment of irrevocable proxy agreements for employee shares under incentive plans provides a clear governance structure for a significant block of shares.

Risks

• The irrevocable proxy agreements grant the CFO sole and absolute discretion over voting a significant block of employee shares, potentially concentrating voting power and influence.
• The vesting of the CFO's newly granted restricted shares and options is contingent on his continued service, which is a standard but notable condition.

Future Outlook

Michael A. Lawless may, at any time, review or reconsider his position in the Issuer, change his purpose, or formulate new plans or proposals. He may also acquire additional shares or other securities as compensation, by purchase, or otherwise, or dispose of some or all of his beneficially owned shares in the open market or privately negotiated transactions. Currently, he does not have any present plans or proposals that relate to, or would result in, actions specified in clauses (a) through (j) of Item 4 to Schedule 13D.

Management Comments

• Michael A. Lawless serves as an executive officer of the Issuer and, in such capacity, may be involved in reviewing transactions involving the Issuer and may have influence over the corporate activities of the Issuer.

Industry Context

This filing is a standard regulatory disclosure for an executive acquiring significant beneficial ownership, often through equity compensation and specific corporate governance mechanisms. The use of irrevocable proxy agreements for employee shares, particularly in the context of Israeli tax regulations (Section 102 Trustee), is a specific but recognized method for managing employee equity and centralizing voting control, reflecting common practices in public companies to align management and employee interests with shareholders.

Comparison to Industry Standards

• The grant of restricted stock and stock options to a Chief Financial Officer as part of an inducement plan is a common practice across industries to attract and retain key executive talent, aligning their long-term interests with company performance.
• The beneficial ownership percentage of 8.6% for a CFO, while significant, is not uncommon when considering both direct holdings and indirect control mechanisms like proxy agreements over employee shares.
• The use of irrevocable proxy agreements for employee shares, especially those held by a Section 102 Trustee under Israeli tax law, is a specific governance mechanism tailored to the company's operational context, which may differ from companies without similar international employee equity structures but serves the general purpose of centralizing voting power for a block of shares.

Corporate Governance

Related Party Transactions

• The grant of 465,000 restricted shares and options to purchase 212,000 shares to Michael A. Lawless, the Chief Financial Officer, under the 2024 Inducement Plan.
• The irrevocable proxy agreements between certain employees (grantors) and Michael A. Lawless (proxyholder) regarding the voting of shares granted under the company's incentive plans.

Stakeholder Impact

• **Shareholders:** Increased voting influence concentrated with the CFO over a portion of employee shares; enhanced alignment of the CFO's long-term interests with shareholder value due to significant equity grants.
• **Employees:** Voting rights for shares held by the Section 102 Trustee are irrevocably delegated to the CFO, limiting their individual voting discretion for those specific shares.
• **Management:** The CFO gains significant voting power over a block of shares, potentially strengthening management's position in corporate governance matters.

Next Steps

• Vesting of Michael A. Lawless's 465,000 restricted shares and 212,000 options in three equal annual installments on June 25, 2026, June 25, 2027, and June 25, 2028.
• Potential future acquisitions or dispositions of shares by Michael A. Lawless as compensation, by purchase, or through market transactions.

Key Dates

Recommendation

This Schedule 13D filing primarily details the beneficial ownership of InspireMD's CFO, Michael A. Lawless, stemming from employee proxy agreements and recent equity compensation. While it demonstrates executive alignment through equity and clarifies a governance mechanism, it does not contain new financial performance data, strategic shifts, or other material information that would warrant a change in investment thesis. It is a standard regulatory disclosure and does not present a strong catalyst for a 'buy' or 'sell' recommendation.

Keywords

InspireMD, Michael Lawless, Schedule 13D, beneficial ownership, common stock, equity incentive plan, restricted stock, stock options, proxy agreement, corporate governance, CFO